China Health Group Inc. (8225.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
42
First IPO Date
July 10, 2003
| Name | Title | Pay | Year Born |
| Yiu Kwong Sun | Adviser for Medical Affairs and Member of Corporate Advisory Board | 0 | 1943 |
| Liang Li | Financial Director | 0 | N/A |
| Xuemei Song | Head of HR Mgmt Dept | 0 | 1968 |
| Guo Raymond | Executive Director & Chief Artificial Intelligence Officer | 0 | 2001 |
| Tsz Ngo Yu | Company Secretary | 0 | 1986 |
| Xia Guo | Executive Chairman | 0 | 1965 |
| Tuo Jin | Joint Chief Technology Officer and Member of Scientific Advisory Board | 0 | 1953 |
China Health Group Inc. functions as an investment holding company, primarily dedicated to supplying clinical research solutions to pharmaceutical and biotechnology firms across the People's Republic of China. Its service offerings span outsourced clinical trials and pharmaceutical development, along with a suite of post-launch support. This includes market research, general medical assistance, specialized medical market insights, and the deployment of medical science liaisons. The company also provides various other medical-related services. Diversifying its operations, China Health Group Inc. is also involved in hospital management, medical tourism, and the running of specialized medical facilities. Furthermore, it offers the "Venturepharma Cloud" platform and is engaged in the sale of drug technologies. The enterprise, originally established in 1998, was known as Venturepharm Laboratories Limited until it rebranded to China Health Group Inc. in January 2015. Its corporate headquarters are located in Beijing, People's Republic of China.